Urinary tract infection (UTI) is a common type of infectious disease globally. The aim of this study was to detect the frequency of fosA3 and fosC2 genes in extended-spectrum β-lactamases (ESBL) and blaDHA, blaCMY-2, and blaCMY-42 genes in AmpC β-lactamases-producing isolates of Escherichia coli. In total, 120 isolates of E. coli were collected from three teaching hospitals between March 2014 and February 2015. Antibiotic susceptibility tests were carried out by disk diffusion method. The presence of blaCMY-2, blaCMY-42, blaDHA, fosA3, and fosC2 genes was detected by polymerase chain reaction (PCR) and sequencing. Of the 120 strains, 92 (76.6%) were identified as ESBL producers, 30 (25%) were determined as AmpC β-lactamase producers, and 24 (20%) had both ESBL and AmpC β-lactamase enzymes. Imipenem, fosfomycin, and nitrofurantoin had the best effect against isolates of E. coli. PCR assay demonstrated that the frequency of blaCMY-2, blaCMY-42, and blaDHA genes among AmpC β-lactamases-producing strains were 39%, 1%, and 17.5%, respectively. This study reports the first detection of fosfomycin resistance in Iran. This study indicated the increasing prevalence of UTI isolates of E. coli-harboring ESBL and AmpC β-lactamases genes in Iran. Therefore, due to the high rate of blaDHA and blaCMY genes and emergence of fosfomycin-resistant E. coli isolates, we recommend continuous monitoring of antibiotic resistance as well as attention to guidelines of infection controls.
Zowawi, H. M., Harris, P. N., Roberts, M. J., Tambyah, P. A., Schembri, M. A., Pezzani, M. D., Williamson, D. A., Paterson, D. L.: The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol 12, 570–584 (2015).
Heidary, M., Bahramian, A., Hashemi, A., Goudarzi, M., Omrani, V. F., Eslami, G., Goudarzi, H.: Detection of acrA, acrB, aac (6′)-Ib-cr, and qepA genes among clinical isolates of Escherichia coli and Klebsiella pneumoniae. Acta Microbiol Immunol Hung 64, 63–69 (2017).
Barber, A. E., Norton, J. P., Spivak, A. M., Mulvey, M. A.: Urinary tract infections: Current and emerging management strategies. Clin Infect Dis 57, 719–724 (2013).
Heidary, M., Bahramian, A., Goudarzi, H., Eslami, G., Hashemi, A., Khoshnood, S.: To study the association between AcrAB and Qep A efflux pumps and ciprofloxacin resistance among Escherichia coli and Klebsiella pneumoniae clinical strains. Arak Med Univ J 19, 1–10 (2016).
Sallem, R. B., Slama, K. B., Estepa, V., Jouini, A., Gharsa, H., Klibi, N., Saenz, Y., Ruiz-Larrea, F., Boudabous, A., Torres, C.: Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia. Eur J Clin Microbiol Infect Dis 31, 1511–1516 (2012).
Jones, G. L., Warren, R., Skidmore, S., Davies, V., Gibreel, T., Upton, M.: Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum β-lactamases. J Antimicrob Chemother 62, 1245–1251 (2008).
Roshani, M., Heidary, M., Goudarzi, H., Hashemi, A., Eslami, G., Yousefi, N.: Investigating the antibacterial effect of methanol and acetone extracts of Urtica dioica and Zataria multiflora against metallo beta-lactamase producing Pseudomonas aeruginosa. J Ilam Uni Med Sci 24, 70–78 (2016).
Karisik, E., Ellington, M., Pike, R., Warren, R., Livermore, D., Woodford, N.: Molecular characterization of plasmids encoding CTX-M-15 β-lactamases from Escherichia coli strains in the United Kingdom. J Antimicrob Chemother 58, 665–668 (2006).
Goudarzi, H., Hashemi, A., Fatemeh, F., Noori, M., Erfanimanesh, S., Yosefi, N., Heidary, M., Koshnood, S., Houri, H. R.: Detection of bla DIM, bla AIM, bla GIM, bla NDM and bla VIM genes among Acinetobacter baumannii strains isolated from hospitalized patients in Tehran hospitals, Iran. Iran J Med Microbiol 9, 32–39 (2016).
Heidary, M., Hashemi, A., Goudarzi, H., Khoshnood, S., Roshani, M., Azimi, H., Goudarzi, M.: The antibacterial activity of Iranian plants extracts against metallo beta-lactamase producing Pseudomonas aeruginosa strains. J Paramed Sci 7, 13–19 (2016).
Mendonça, N., Leitão, J., Manageiro, V., Ferreira, E., Caniça, M.: Spread of extended-spectrum β-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob Agents Chemother 51, 1946–1955 (2007).
Yan, J. J., Ko, W. C., Jung, Y. C., Chuang, C. L., Wu, J. J.: Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 β-lactamase in a university hospital in Taiwan. J Clin Microbiol 40, 3121–3126 (2002).
Ho, P. L., Chan, J., Lo, W. U., Lai, E. L., Cheung, Y. Y., Lau, T. C., Chow, K. H.: Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates. J Med Microbiol 62, 1707–1713 (2013).
Mendes, A. C., Rodrigues, C., Pires, J., Amorim, J., Ramos, M. H., Novais, Â., Peixe, L.: Importation of fosfomycin resistance fosA3 gene to Europe. Emerg Infect Dis 22, 346–348 (2016).
Sato, N., Kawamura, K., Nakane, K., Wachino, J. I., Arakawa, Y.: First detection of fosfomycin resistance gene fosA3 in CTX-M-producing Escherichia coli isolates from healthy individuals in Japan. Microb Drug Resist 19, 477–482 (2013).
Lee, S. Y., Park, Y. J., Yu, J. K., Jung, S., Kim, Y., Jeong, S. H., Arakawa, Y.: Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. J Antimicrob Chemother 67, 2843–2847 (2012).
Hou, J., Huang, X., Deng, Y., He, L., Yang, T., Zeng, Z., Chen, Z., Liu, J. H.: Dissemination of fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China. Antimicrob Agents Chemother 56, 2135–2138 (2012).
Ho, P., Chan, J., Lo, W., Law, P., Li, Z., Lai, E., Chow, K. H.: Dissemination of plasmid-mediated fosfomycin resistance fosA3 among multidrug-resistant Escherichia coli from livestock and other animals. J Appl Microbiol 114, 695–702 (2013).
Wachino, J., Yamane, K., Suzuki, S., Kimura, K., Arakawa, Y.: Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob Agents Chemother 54, 3061–3064 (2010).
Heidary, M., Goudarzi, H., Hashemi, A., Eslami, G., Goudarzi, M., Chirani, A. S., Amraei, S.: Prevalence of quinolone resistance genes in Klebsiella pneumoniae strains isolated from hospitalized patients during 2013–2014. Arch Pediatr Infect Dis, e38343 (2016). doi:10.5812/pedinfect.38343 [Epub Ahead of Print].
Clinical and Laboratory Standards Institute (CLSI): Performance Standard for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. CLSI document M100_s17. CLSI, Wayne, PA, USA, 2013.
Lob, S. H., Nicolle, L. E., Hoban, D. J., Kazmierczak, K. M., Badal, R. E., Sahm, D. F.: Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010–2014. Diagn Microbiol Infect Dis 85, 459–465 (2016).
Shayan, S., Bokaeian, M., Shahraki, S.: Prevalence and molecular characterization of AmpC-producing clinical isolates of Escherichia coli from Southeastern Iran. Microb Drug Resist 20, 104–107 (2014).
Saffar, H., Niaraki, N. A., Tali, A. G., Baseri, Z., Abdollahi, A., Yalfani, R.: Prevalence of AmpC β-lactamase in clinical isolates of Escherichia coli, Klebsiella spp., and Proteus mirabilis in a Tertiary Hospital in Tehran, Iran. Jundishapur J Microbiol 9, e39121 (2016).
Domokos, J., Kristóf, K., Szabó, D.: Plasmid-mediated quinolone resistance among extended-spectrum beta-lactamase producing Enterobacteriaceae from bloodstream infections. Acta Microbiol Immunol Hung 63, 313–323 (2016).